Rightmove plc (LON:RMV – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 563.43 ($7.54) and traded as high as GBX 634 ($8.48). Rightmove shares last traded at GBX 628.08 ($8.40), with a volume of 1,990,270 shares traded.
Analysts Set New Price Targets
RMV has been the subject of a number of research reports. Shore Capital restated a “buy” rating on shares of Rightmove in a report on Monday, September 2nd. JPMorgan Chase & Co. restated an “underweight” rating and issued a GBX 483 ($6.46) price target on shares of Rightmove in a research note on Thursday, June 6th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 650 ($8.69) price objective on shares of Rightmove in a research note on Tuesday, September 3rd. Two investment analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of GBX 602.67 ($8.06).
Get Our Latest Report on Rightmove
Rightmove Stock Up 1.7 %
Rightmove Cuts Dividend
The firm also recently announced a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 26th will be issued a GBX 3.70 ($0.05) dividend. This represents a yield of 0.65%. The ex-dividend date is Thursday, September 26th. Rightmove’s dividend payout ratio (DPR) is presently 3,600.00%.
About Rightmove
Rightmove plc, together with its subsidiaries, operates online digital property advertising and information portals in the United Kingdom and internationally. The company operates through Agency, New Homes, and Other segments. The Agency segment provides property resale and letting advertising services on its platforms.
Read More
- Five stocks we like better than Rightmove
- Trading Stocks: RSI and Why it’s Useful
- Why Lennar Stock Could Be the Best Play in the Housing Market
- P/E Ratio Calculation: How to Assess Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Investing In Preferred Stock vs. Common Stock
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Rightmove Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rightmove and related companies with MarketBeat.com's FREE daily email newsletter.